Preliminary data presented at the 2022 Annual Meeting of the Consortium of Multiple indicates that TMS may help with the depressive symptoms that people with multiple sclerosis (MS) patients experience. This quantitative study consisting of 20 individuals with MS was conducted to assess the efficacy of using TMS for depression. Their sessions consisted of 10 treatment sessions for 10 consectutive days and aimed to target the primary motor cortex as well as the left dorsolateral prefrontal cortex. Following the treatments, 65% of patients noticed improvements in their depressive symptoms as indicated by Beck Depression Inventory Score.
This data is instrumental the patients experiencing depressive symptoms associated with MS. The findings indicate the potential use of TMS to treat depressive symptoms for patients with MS. MS patients experience several physical and mental symptoms with depression being a frequent symptom.
Read more about this story here.